Ablative or non-ablative therapy for Graves' hyperthyroidism in patients with ophthalmopathy?

Journal of Endocrinological Investigation

Volumn 21, Issue 7, 1998, Pages 468-471

  Marcocci, C ^a   Bartalena, L ^a   Pinchera, A ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Graves' ophthalmopathy; Radioiodine; Thionamides; Thyroidectomy

Indexed keywords

ANTITHYROID AGENT; RADIOACTIVE IODINE; THYROID HORMONE;

EYE DISEASE; GRAVES DISEASE; HUMAN; SHORT SURVEY; SUBTOTAL THYROIDECTOMY; THYROID SURGERY; THYROIDECTOMY; TREATMENT PLANNING;

EID: 0031757262     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347329     Document Type: Short Survey

References (17)

1. Bahn R.S., Heufelder A.E. Pathogenesis of Graves' ophthalmopathy. N. Engl. J. Med. 329: 1468, 1993.
2. Marcocci C., Bartalena L., Bogazzi F., Panicucci M., Pinchera A. Studies on the occurrence of ophthalmopathy in Graves' disease. Acta Endocrinol. (Copenh.) 120: 473, 1989.
3. Prummel M.F., Wiersinga W.M., Mourits M.P., Koornneef L., Berghout A., van der Gaag R. Influence of abnormal thyroid function on the severity of accompanying Graves' ophthalmopathy. Arch. Intern. Med. 150: 1098, 1990.
4. Marcocci C., Bartalena L., Bogazzi F., Bruno-Bossio G., Pinchera A. Relationship between Graves' ophthalmopathy and type of treatment of Graves' hyperthyroidism thyroid. Thyroid 2: 171, 1992.
5. Vitti P., Rago T., Chiovato L., Santini F., Fiore E., Rocchi R., Martino E., Pinchera A. Clinical features of patients with Graves' disease. Thyroid 7: 369, 1997.
6. Burch H.B., Wartotsky L. Grave's ophthalmopathy: current concepts regarding pathogenesis and management. Endocr. Rev. 14: 747, 1993.
7. Pinchera A., Bartalena L., Marcocci C. Radioiodine may be bad for Graves' ophthalmopathy, but... J. Clin. Endocrinol. Metab. 80: 342, 1995.
8. Bartalena L., Marcocci C., Bogazzi F., Manetti L., Tanda M.L., Dell'Unto E., Bruno Bossio G., Nardi M., Bartolomei M.P., Lepri A., Rossi G., Martino E., Pinchera A. Relationship between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N.Engl. J. Med. 338: 73, 1998.
9. Gorman C.A. Radioiodine therapy does not aggravate Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 80: 340, 1995.
10. Patwardhan N.A., Moront M., Rao S., Rossi S., Braverman L.E. Surgery still has a role in Graves' hyperthyroidism. Surgery 114: 1108, 1993.
11. Catz B., Perzik S.L. Total thyroidectomy in the management of thyrotoxic and euthyroid Graves' disease. Am J. Surg. 118: 434, 1969.
12. Marcocci C., Bartalena L., Bruno-Bossio G., Manetti L., Tanda M.L., Miccoli P., lacconi P., Bartolomei M.P., Nardi M., Pinchera A. The course of Graves' ophthalmopathy is not negatively influenced by near total thyroidectomy: A randomized, single blind study, (submitted for publication).
13. Fenzi G.F., Hashizume K., Roudebush C., DeGroot L.L. Changes in thyroid-stimulating immunoglobulins during antithyroid therapy. J. Clin. Endocrinol. Metab. 48: 572, 1979.
14. Tallstedt L., Lundell G., Blomgren H., Bring J. Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment? Eur. J. Endocrinol. 130: 494, 1994.
15. Miccoli P., Vitti P., Rago T., lacconi P., Bartalena L., Bogazzi F., Fiore E., Valeriano R., Chiovato L., Rocchi R., Pinchera A. Surgical treatment of Graves' disease: subtotal or total thyroidectomy? Surgery 120: 1020, 1996.
16. Bauer F.K., Katz B. Radioactive iodine therapy for progressive malignant exophthalmos. Acta Endocrinol. 51: 15, 1966.
17. De Groot L.J. Retro-orbit radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy. J. Clin. Endocrinol. Metab. 80: 339, 1995.